Skip to content

Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer

Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer: a Population Study of the US Database and a Chinese Multi-institutional Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05572151
Enrollment
7694
Registered
2022-10-07
Start date
2009-01-01
Completion date
2018-12-31
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

A multi-institutional registry of collected data on patients with rectal cancer who underwent surgical resection between January 2009 and December 2018 at the departments of colorectal surgery of five medical institutions in China

Detailed description

A multi-institutional registry of collected data on patients with rectal cancer who underwent surgical resection between January 2009 and December 2018 at the departments of colorectal surgery of five medical institutions in China (National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Changhai Hospital, Naval Medical University; The Second Affiliated Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Guangxi Medical University)

Interventions

PROCEDURElymph node number

Lymph nodes were harvested during surgical resection of rectal cancer

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* Rectal cancer patients in stage I-III who underwent surgical resection for first primary rectal cancer with at least one lymph node were eligible

Exclusion criteria

* Patients with missing values on lymph node count and clinical features were excluded

Design outcomes

Primary

MeasureTime frameDescription
lymph node numberduring the surgerylymph nodes were harvested during surgical resection of rectal cancer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026